Glucovance: Dual-Action Glycemic Control for Type 2 Diabetes
| Product dosage: 2.5mg/400mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.60 | $48.02 (0%) | 🛒 Add to cart |
| 60 | $1.35 | $96.03 $81.03 (16%) | 🛒 Add to cart |
| 90 | $1.23 | $144.05 $111.04 (23%) | 🛒 Add to cart |
| 120 | $1.16 | $192.06 $139.05 (28%) | 🛒 Add to cart |
| 180 | $1.08 | $288.09 $194.06 (33%) | 🛒 Add to cart |
| 270 | $1.00 | $432.14 $270.09 (38%) | 🛒 Add to cart |
| 360 | $0.80
Best per pill | $576.19 $288.09 (50%) | 🛒 Add to cart |
| Product dosage: 5mg/500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.70 | $51.02 (0%) | 🛒 Add to cart |
| 60 | $1.50 | $102.03 $90.03 (12%) | 🛒 Add to cart |
| 90 | $1.40 | $153.05 $126.04 (18%) | 🛒 Add to cart |
| 120 | $1.33 | $204.07 $160.05 (22%) | 🛒 Add to cart |
| 180 | $1.27 | $306.10 $228.07 (25%) | 🛒 Add to cart |
| 270 | $1.20 | $459.15 $324.11 (29%) | 🛒 Add to cart |
| 360 | $0.95
Best per pill | $612.20 $342.11 (44%) | 🛒 Add to cart |
Glucovance is a prescription medication combining two established antidiabetic agents, metformin hydrochloride and glyburide, into a single tablet. It is specifically formulated for the management of type 2 diabetes mellitus in adults when diet and exercise alone, or a single agent, do not provide adequate glycemic control. This fixed-dose combination leverages complementary mechanisms of action to address multiple pathophysiological defects of the disease, offering a streamlined therapeutic approach that may enhance patient adherence. Its use is indicated as an adjunct to diet and exercise, and treatment should be initiated under the supervision of a healthcare professional familiar with the risks and management of diabetes.
Features
- Fixed-dose combination of metformin hydrochloride and glyburide.
- Available in multiple tablet strengths (e.g., 1.25 mg/250 mg, 2.5 mg/500 mg, 5 mg/500 mg glyburide/metformin).
- Oral tablet formulation for convenient twice-daily dosing.
- Works by decreasing hepatic glucose production and intestinal absorption of glucose (metformin) and stimulating insulin release from pancreatic beta cells (glyburide).
- May improve glycemic control more effectively than either component alone.
Benefits
- Provides a simplified treatment regimen, potentially improving medication adherence compared to taking multiple separate pills.
- Targets two key defects in type 2 diabetes: insulin resistance and insufficient insulin secretion.
- Can lead to significant reductions in both fasting and postprandial blood glucose levels.
- Helps lower HbA1c, a key long-term marker of glycemic control.
- May delay the need for insulin therapy in some patients.
- Offers the convenience of a combination therapy with a established safety profile for its individual components.
Common use
Glucovance is commonly prescribed for adults with type 2 diabetes mellitus whose hyperglycemia cannot be satisfactorily controlled with diet and exercise alone. It is also used in patients already being treated with a sulfonylurea (like glyburide) and/or metformin as separate tablets. It serves as a second-line or add-on therapy when monotherapy fails to achieve or maintain target HbA1c levels. The goal of treatment is to lower elevated blood glucose levels closer to the normal range, thereby reducing the risk of diabetic complications.
Dosage and direction
The dosage of Glucovance must be individualized based on the patient’s current regimen, effectiveness, and tolerability. It is typically administered twice daily with meals. The recommended starting dose is often based on the patient’s pre-existing doses of metformin and/or glyburide.
- Initial Dose: For patients not previously on metformin or a sulfonylurea, a starting dose of 1.25 mg/250 mg once or twice daily with meals is common.
- Dose Titration: Dosage adjustments should be made in increments of no more than 5 mg glyburide/500 mg metformin per day, at approximately two-week intervals.
- Maximum Dose: The maximum recommended daily dose is 20 mg glyburide/2000 mg metformin.
- Administration: Tablets should be swallowed whole with a glass of water and taken with meals to reduce the potential for gastrointestinal upset. Dosing should not be split; the fixed combination must be maintained.
Precautions
- Lactic Acidosis: A rare but serious metabolic complication that can occur due to metformin accumulation. Risk factors include renal impairment, congestive heart failure, dehydration, excessive alcohol intake, and acute hemodynamic compromise. Symptoms include malaise, myalgias, respiratory distress, and abdominal pain; if suspected, discontinue Glucovance and seek immediate medical attention.
- Hypoglycemia: All sulfonylureas, including glyburide, can cause severe hypoglycemia. Risk is increased by skipped meals, strenuous exercise, alcohol consumption, and use of other hypoglycemic agents.
- Renal Function: Metformin is contraindicated in patients with renal disease or renal dysfunction. Renal function should be assessed before initiation and regularly thereafter.
- Hepatic Impairment: Use with caution in patients with hepatic disease, as impaired liver function can increase the risk of hypoglycemia and lactic acidosis.
- Vitamin B12 Deficiency: Long-term use of metformin has been associated with vitamin B12 deficiency; periodic monitoring of hematological parameters is advised.
- Surgery & Radiologic Procedures: Glucovance should be temporarily discontinued at the time of, or prior to, surgical procedures or intravascular iodinated contrast imaging and withheld for 48 hours afterwards, only restarting after renal function has been re-evaluated and found to be normal.
Contraindications
- Renal disease or renal dysfunction (e.g., serum creatinine levels ≥1.5 mg/dL in males, ≥1.4 mg/dL in females).
- Acute or chronic metabolic acidosis, including diabetic ketoacidosis.
- History of a hypersensitivity reaction to metformin, glyburide, or any other sulfonylurea or biguanide.
- During periods of hemodynamic instability (e.g., shock, acute congestive heart failure requiring pharmacologic management).
- Severe hepatic impairment.
Possible side effect
Common side effects are often related to the gastrointestinal system or hypoglycemia. Not all patients will experience these effects.
- Very Common (≥1/10): Hypoglycemia, nausea, vomiting, diarrhea, abdominal pain, metallic taste.
- Common (≥1/100 to <1/10): Flatulence, anorexia, asthenia (lack of energy).
- Uncommon (≥1/1,000 to <1/100): Skin reactions such as rash, urticaria, and pruritus.
- Rare (≥1/10,000 to <1/1,000): Lactic acidosis, hepatitis, elevated liver enzymes.
- Very Rare (<1/10,000): Porphyria, hyponatremia, leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, photosensitivity reactions.
Drug interaction
Glucovance has a significant potential for drug interactions. Inform your doctor of all medications you are taking.
- Drugs that may increase hypoglycemic risk: Other antidiabetic agents (insulin, thiazolidinediones), angiotensin-converting enzyme (ACE) inhibitors, beta-blockers (may mask hypoglycemia symptoms), chloramphenicol, fluconazole, sulfonamides, salicylates, NSAIDs, probenecid, MAO inhibitors, pentoxifylline.
- Drugs that may decrease hypoglycemic effect: Corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, isoniazid, diuretics.
- Drugs affected by glyburide: Beta-blockers may potentiate hypoglycemia and mask its warning signs.
- Nifedipine can increase the absorption of metformin.
- Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim, vancomycin) that are eliminated by renal tubular secretion may interact with metformin by competing for common renal tubular transport systems.
- Alcohol: Potentiates the effect of metformin on lactate metabolism and increases the risk of lactic acidosis. Acute alcohol intoxication is contraindicated.
Missed dose
If a dose is missed, it should be taken as soon as remembered with food, unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the usual dosing schedule. Do not take a double dose to make up for a missed one, as this significantly increases the risk of hypoglycemia.
Overdose
Overdose of Glucovance is a medical emergency and is associated primarily with a risk of severe hypoglycemia and lactic acidosis.
- Hypoglycemia: Symptoms include confusion, drowsiness, sweating, tremors, seizures, and loss of consciousness. Mild hypoglycemia should be treated with oral glucose. Severe hypoglycemia constitutes a medical emergency requiring hospitalization and administration of intravenous glucose or glucagon.
- Lactic Acidosis: Hospitalization is immediate. Lactic acidosis is characterized by acidotic dyspnea, abdominal pain, and hypothermia, followed by coma. Hemodialysis is effective for removing accumulated metformin and correcting acidosis.
Storage
- Store at room temperature between 20°C to 25°C (68°F to 77°F).
- Keep the bottle tightly closed to protect from moisture.
- Keep out of reach of children and pets.
- Do not use after the expiration date printed on the bottle.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided may not cover all possible uses, directions, precautions, drug interactions, or adverse effects.
Reviews
- “As an endocrinologist, I find Glucovance to be a valuable tool for patients struggling with control on monotherapy. The combination improves adherence and often gets us to our HbA1c target faster. Vigilance for hypoglycemia, especially in elderly patients, is paramount.” – Dr. E. Lawson, MD
- “Switching to Glucovance simplified my daily routine from three pills to two. My morning fasting sugars have been much more consistent. I did experience some stomach upset initially, but it subsided after a few weeks.” – Patient, 58
- “The dual mechanism provides a robust physiological approach to glucose management. It’s a well-studied combination that I have confidence in prescribing, though renal function must be monitored diligently.” – Clinical Pharmacist
- “Effective for control, but the risk of low blood sugar is real. I had one significant episode that was quite frightening. It requires careful attention to meal timing.” – Patient, 64